Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ALRTFALR Technologies SG Ltd.

OTC · CIK 0001930419
Filer categoryNon-accelerated filer
Entity typeother
SIC3841 Surgical & Medical Instruments & Apparatus
FY end—
XBRL facts185

Identity from submissions API

NameALR Technologies SG Ltd.
CIK0001930419
TickersALRTF
ExchangesOTC
Entity typeother
CategoryNon-accelerated filer
SIC3841 Surgical & Medical Instruments & Apparatus
EIN000000000
LEI—
Fiscal year end—
State of incorporation—
Phone6531292924
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ALR Technologies SG Pte. Ltd. (2022-05-24T00:00:00.000Z → 2022-09-23T00:00:00.000Z)
Business address
9 RAFFLES PLACE
#26-01 REPUBLIC PLAZA
SINGAPORE
U0
048619
Singapore
Mailing address
9 RAFFLES PLACE
#26-01 REPUBLIC PLAZA
SINGAPORE
U0
048619
Singapore

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

50 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-06-30 6-K alrt_6k.htm 0001903596-26-000269 000-56491 261139900 34 1243392
2026-05-20 6-K alrt_6k.htm 0001903596-26-000232 000-56491 261003066 34 717609
2026-05-15 3 xslF345X06/ownership.xml 0001903596-26-000225 5991
2026-04-30 20-F alrt_20f.htm 0001903596-26-000182 000-56491 26927025 34 10622093 1 1
2026-04-09 3 xslF345X06/ownership.xml 0001903596-26-000145 6653
2026-04-09 3 xslF345X06/ownership.xml 0001903596-26-000144 5448
2026-04-06 3 xslF345X06/ownership.xml 0001903596-26-000133 11297
2026-04-06 3 xslF345X06/ownership.xml 0001903596-26-000127 8995
2026-03-17 3 xslF345X02/ownership.xml 0001903596-26-000079 10834
2026-01-05 6-K alrt_6k.htm 0001903596-26-000001 000-56491 26504938 34 12537
2025-12-30 6-K alrt_6k.htm 0001903596-25-000596 000-56491 251613315 34 622522
2025-12-30 6-K alrt_6k.htm 0001903596-25-000595 000-56491 251613270 34 26798
2025-07-07 6-K alrt_6k.htm 0001903596-25-000332 000-56491 251108800 34 18061
2025-06-26 6-K alrt_6k.htm 0001903596-25-000323 000-56491 251078200 34 843493
2025-05-02 20-F/A arl_20fa.htm 0001903596-25-000234 000-56491 25907213 34 10088892 1 1
2025-05-01 NT 20-F alrt_nt20f.htm 0001903596-25-000225 000-56491 25901798 34 23522
2025-05-01 20-F arl_20f.htm 0001903596-25-000224 000-56491 25897745 34 9171589 1 1
2024-12-30 6-K alrt_6k.htm 0001903596-24-000760 000-56491 241589175 34 3195436
2024-07-08 UPLOAD filename1.pdf 0000000000-24-007692 000-56491 39884
2024-07-01 20-F/A alrt_20fa.htm 0001903596-24-000395 000-56491 241089355 34 8993480 1 1
2024-06-11 CORRESP filename1.htm 0001903596-24-000384 37667
2024-05-28 UPLOAD filename1.pdf 0000000000-24-006101 000-56491 50705
2024-04-30 20-F alrt_20f.htm 0001903596-24-000264 000-56491 24894178 34 9115406 1 1
2023-12-29 6-K alrt_6k.htm 0001903596-23-000974 000-56491 231524309 34 666957
2023-09-28 6-K alrt_6k.htm 0001903596-23-000756 000-56491 231290513 34 886151
2023-08-10 6-K alrt_6k.htm 0001903596-23-000604 000-56491 231160664 34 921157
2023-06-06 6-K alrt_6k.htm 0001903596-23-000472 000-56491 23996422 34 27270
2023-05-01 20-F alr_20f.htm 0001903596-23-000359 000-56491 23873949 34 12760805 1 1
2023-01-06 6-K alrt_6k.htm 0001903596-23-000022 000-56491 23514548 34 836950
2022-12-07 6-K alrt_6k.htm 0001903596-22-000895 000-56491 221450226 34 859814
2022-11-18 SC 13D/A sfssc13d111122.htm 0001903596-22-000830 005-93820 221399852 34 161958
2022-11-14 SC 13D sfssc13d111122.htm 0001903596-22-000782 005-93820 221380079 34 140510
2022-11-10 8-K12G3 alrt_6k.htm 8.01 0001903596-22-000770 000-56491 221375432 34 15755
2022-10-03 425 f2salr8k093022.htm 0001903596-22-000627 2019031
2022-10-03 425 f2salr8k093022.htm 0001903596-22-000625 333-265166 221287062 34 2019032
2022-09-29 424B3 sfsalr424b3092822.htm 0001903596-22-000617 333-265166 221280555 33 2910831
2022-09-23 EFFECT xslEFFECTX01/primary_doc.xml F-4,,2022-09-23 17:00:00 9999999995-22-002807 333-265166 221263516 33 1619
2022-09-21 SEC STAFF LETTER filename1.pdf 9999999997-22-004231 275165
2022-09-21 CORRESP filename1.htm 0001903596-22-000600 7645
2022-09-15 F-4/A sfsalrf091522.htm 0001903596-22-000589 333-265166 221245970 33 3526478
2022-09-15 CORRESP filename1.htm 0001903596-22-000590 9328
2022-09-14 SEC STAFF LETTER filename1.pdf 9999999997-22-004169 275967
2022-09-08 CORRESP filename1.htm 0001903596-22-000570 16027
2022-09-08 F-4/A sfsalrf0801722.htm 0001903596-22-000569 333-265166 221234318 33 5987509
2022-08-17 UPLOAD filename1.pdf 0000000000-22-008761 44170
2022-08-05 F-4/A sfsalrf080222.htm 0001903596-22-000494 333-265166 221141794 33 6621528
2022-08-05 CORRESP filename1.htm 0001903596-22-000495 19941
2022-07-15 UPLOAD filename1.pdf 0000000000-22-007475 46309
2022-06-21 F-4/A sfsalrf4051722.htm 0001903596-22-000391 333-265166 221028453 33 7027941
2022-05-24 F-4 sfsalrf4051722.htm 0001903596-22-000359 333-265166 22955966 33 3417643

Latest XBRL company facts

One latest value per concept from companyfacts (185 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 645.47M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.39M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 579,012 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.29M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AccountsPayableFairValueDisclosure Accounts Payable, Fair Value Disclosure CAD 120,905 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 41,100 2023-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 100,849 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -844 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 86.69M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 86,869 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 113,912 2022-01-01 2022-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.87M 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AdvancesToAffiliate Advances to Affiliate SGD 2.50M 2022-09-06 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 17.29M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap Assets Assets USD 47,374 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap Cash Cash USD 20,305 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure CAD 1,372 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 20,305 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -20,352 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value SGD 2.34M 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.004 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.19B 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 551.97M 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 551.97M 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap CommonStockValue Common Stock, Value, Issued USD 31.49M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -22.06M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap CostOfRevenue Cost of Revenue USD 22,096 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 1.19M 2025-04-16 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.2 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal SGD 2.50M 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 130,000 2024-01-16 2024-01-17 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 125,000 2024-01-16 2024-01-17 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 7.26M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2,905 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 34.57M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 18.53M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 7,000 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 12.63M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 3.68M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 375,000 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.03 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.04 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.21 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -6,991 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 979,143 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 18.27M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap FairValueConcentrationOfRiskDerivativeFinancialInstrumentsLiabilities Fair Value, Concentration of Risk, Derivative Instruments, Liabilities USD 315,000 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap FairValueConcentrationOfRiskLoansReceivable Fair Value, Concentration of Risk, Loans Receivable SGD 2.34M 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -212,665 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -139,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 276,554 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap GrossProfit Gross Profit USD 3,440 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -2.88M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -2.26M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 309,495 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 41,100 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 203,345 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -20 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -327,246 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -41,726 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncreaseDecreaseInRecoverablePropertyDamageCosts Increase (Decrease) in Recoverable Property Damage Costs USD 35,100 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 6.12B 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap IncrementalCommonSharesAttributableToWrittenPutOptions Incremental Common Shares Attributable to Dilutive Effect of Written Put Options shares 311.47M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestAndDividendsPayableCurrent Interest and Dividends Payable, Current USD 6.23M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestExpense Interest Expense USD -19.74M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 530,591 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 19.74M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestExpenseOtherLongTermDebt Interest Expense, Other Long-term Debt USD 24,000 2023-01-01 2023-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 17.29M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 23,315 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap InterestPayableCurrent Interest Payable, Current USD 3.73M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap InventoryNet Inventory, Net USD 10,843 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LegalFees Legal Fees SGD 2.50M 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap Liabilities Liabilities USD 39.91M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 47,374 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LiabilitiesCurrent Liabilities, Current USD 32.07M 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap LineOfCreditAssumed1 Line of Credit Assumed USD 3,000 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 15.30M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LineOfCreditFacilityPeriodicPayment Line of Credit Facility, Periodic Payment USD 1.83M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LineOfCreditFacilityPeriodicPaymentPrincipal Line of Credit Facility, Periodic Payment, Principal USD 1.83M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 23.20M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 255,000 2024-01-16 2024-01-17 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 139,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LoansAssumed1 Loans Assumed USD 113,912 2022-01-01 2022-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap LoansPayableCurrent Loans Payable, Current USD 3.83M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LongtermDebtPercentageBearingFixedInterestAmount Long-term Debt, Percentage Bearing Fixed Interest, Amount USD 6.24M 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap LongtermDebtPercentageBearingVariableInterestAmount Long-term Debt, Percentage Bearing Variable Interest, Amount USD 100,000 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap LongTermDebtPercentageBearingVariableInterestRate Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate pure 0.01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 23.20M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 1.84M 2022-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.85M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.87M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -22.06M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NoncashContributionExpense Noncash Contribution Expense USD 32,509 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -19.18M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NotesAssumed1 Notes Assumed USD 75,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NotesIssued1 Notes Issued USD 24,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NotesPayable Notes Payable USD 3.09M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap NotesPayableCurrent Notes Payable, Current USD 2.16M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap OperatingExpenses Operating Expenses USD 2.88M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 4.27M 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 34.57M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap OriginationOfNotesReceivableFromRelatedParties Origination of Notes Receivable from Related Parties USD 20,000 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap OtherAdditionalCapital Other Additional Capital SGD 160,056 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -7.48M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD -6,991 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap OtherIncome Other Income USD 26,460 2020-01-01 2020-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap OtherLoansPayable Other Loans Payable SGD 3.00M 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -245,000 2022-01-01 2022-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -41,100 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap OtherNotesPayable Other Notes Payable USD 2.16M 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 1.40M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap OtherShortTermBorrowings Other Short-term Borrowings USD 2.42M 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 1.83M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 1.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 45,270 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 16,226 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap PrincipalAmountOutstandingOfLoansHeldInPortfolio Principal Amount Outstanding of Loans Held-in-portfolio USD 15.26M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromCommissionsReceived Proceeds from Commissions Received USD 200,767 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD 72,834 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap ProceedsFromInsurancePremiumsCollected Proceeds from Insurance Premiums Collected USD 160,000 2023-01-01 2023-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 744,655 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromIssuanceOfFinancialServicesObligations Proceeds from Issuance of Financial Services Obligations USD 200,000 2020-01-01 2020-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 6,000 2024-01-01 2024-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.83M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromLoans Proceeds from Loans USD 1.78M 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.09M 2024-01-01 2024-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 276,556 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 22,419 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 403,880 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ProfessionalFees Professional Fees USD 617,687 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 22.06M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 41,100 2024-01-01 2024-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 310,603 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 649,708 2022-01-01 2022-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 793,327 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 1.06M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -158.04M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 25,536 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap Revenues Revenues USD 25,536 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap SecuritiesBorrowed Securities Borrowed USD 2.16M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.47M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.00M 2022-01-01 2022-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.05 2025-06-29 2025-07-01 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) shares 1.00M 2025-06-29 2025-07-01 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.23 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.45 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 5.00M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 25.00M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 120.27M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease) shares 182.20M 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.03 2025-05-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0.037 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 0.003 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 411.97M 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.045 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 379,019 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.05 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.015 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.05 2023-01-01 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 39.30M 2025-05-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -39.86M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -39.86M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssued1 Stock Issued USD 120,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 370,000 2022-01-01 2022-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 120,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 375,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 18.27M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 744,655 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -6,991 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 32,509 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 75,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) USD 600,124 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 5.19B 2023-12-31 2023 FY 20-F/A 2024-07-01 0001903596-24-000395
us-gaap UnrealizedGainOnForeignCurrencyDerivativesBeforeTax Unrealized Gain on Foreign Currency Derivatives, before Tax USD 81,495 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001903596-23-000359
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 7.26M 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 273,899 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation USD 560,461 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -7.26M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 606.99M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-30 0001903596-26-000182
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 598.92M 2024-01-01 2024-12-31 2024 FY 20-F/A 2025-05-02 0001903596-25-000234

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →